RT Journal Article
SR Electronic
T1 Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.21.21255873
DO 10.1101/2021.04.21.21255873
A1 Vahidy, Farhaan S.
A1 Pischel, Lauren
A1 Tano, Mauricio E.
A1 Pan, Alan P.
A1 Boom, Marc L.
A1 Sostman, Henry Dirk
A1 Nasir, Khurram
A1 Omer, Saad B.
YR 2021
UL http://medrxiv.org/content/early/2021/04/23/2021.04.21.21255873.abstract
AB Background Covid-19 has caused significant global mortality. Multiple vaccines have demonstrated efficacy in clinical trials though real-world effectiveness of vaccines against Covid-19 mortality in clinically and demographically diverse populations has not yet been reported.Methods We used a retrospective cohort assembled from a cross-institution comprehensive data repository. Established patients of the health care system were categorized as not immunized, partially immunized, or fully immunized against SARS-CoV-2 with an mRNA vaccine through April 4, 2021. Outcomes were Covid-19 related hospitalization and death.Results Of the 91,134 established patients, 70.2% were not immunized, 4.5% were partially immunized and 25.4% were fully immunized. Among the fully immunized 0.7% had a Covid-19 hospitalization, whereas 3.4% among the partially immunized and 2.7% non-immunized individuals were hospitalized with Covid-19. Of the 225 deaths among Covid-19 hospitalizations, 219 (97.3%) were in the not immunized, 5 (2.2%) in the partially immunized, and 1 (0.0041%) in the fully immunized group. mRNA vaccines were 96% (95%CI: 95 — 99) effective at preventing Covid-19 related hospitalization and 98.7% (95%CI: 91.0 — 99.8) effective at preventing Covid-19 related death when participants were fully vaccinated. Partial vaccination was 77% (95%CI: 71 — 82) effective at preventing hospitalization and 64.2% (95%CI: 13.0 — 85.2) effective at preventing death. Vaccine effectiveness at preventing hospitalization was conserved across subgroups of age, race, ethnicity, Area Deprivation Index, and Charlson Comorbidity Index.Conclusions In a large, diverse cohort in the United States, full immunization with mRNA vaccines was highly effective in the real-world scenario at preventing Covid-19 related hospitalization and death.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFinancial support for the COVID-19 Surveillance and Outcomes Registry (CURATOR) was provided by Houston Methodist and the Houston Methodist Academic Institute. The study was partially funded by the Yale Institute for Global Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Houston Methodist Institutional Review Board (PRO 00025445:1)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are collected under the Houston Methodist IRB approved project, CURATOR. Reasonable requests for a fully de-identified dataset can be made to the corresponding author. These requests will be evaluated on an individual basis by the CURATOR governance committee and the IRB.